Status:
COMPLETED
Cytochrome P450's Pharmacogenomics in Chronic Pain Patients
Lead Sponsor:
University of Bologna
Conditions:
Analgesia
CYP2D6 Polymorphism
Eligibility:
All Genders
18-90 years
Brief Summary
The use of titrated drugs is at the base of a successful antalgic treatment in order to provide both an adequate relief and a satisfactory tolerability profile. These molecules, though, have a varying...
Eligibility Criteria
Inclusion
- Diagnosis of chronic pain
Exclusion
- \-
Key Trial Info
Start Date :
January 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 23 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03411759
Start Date
January 8 2018
End Date
March 23 2018
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andrea Fanelli
Bologna, Italy, 40138